YPSN.SW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 11:30):

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies...

Stats
Today's Volume	19 322.00
Average Volume	14 668.00
Market Cap	4.97B
EPS	CHF0 ( 2023-11-15 )
Next earnings date	( CHF0 ) 2024-05-21
Last Dividend	CHF0 ( N/A )
Next Dividend	CHF0 ( N/A )
P/E	68.35
ATR14	CHF0.796 (0.22%)

Volume Correlation

Long: 0.11 (neutral)

Short: 0.61 (weak)

Signal:(52.077) Neutral

Ypsomed Holding AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ypsomed Holding AG Correlation - Currency/Commodity

0.50
( neutral )

0.69
( moderate )

-0.50
( neutral )

-0.01
( neutral )

-0.06
( neutral )

-0.29
( neutral )

Ypsomed Holding AG Financials

Annual	2022
Revenue:	CHF497.46M
Gross Profit:	CHF140.59M (28.26 %)
EPS:	CHF3.82

Q2	2023
Revenue:	CHF255.39M
Gross Profit:	CHF87.82M (34.39 %)
EPS:	CHF2.68

Q4	2022
Revenue:	CHF253.22M
Gross Profit:	CHF75.14M (29.68 %)
EPS:	CHF2.63

Q3	2022
Revenue:	CHF126.61M
Gross Profit:	CHF37.57M (29.68 %)
EPS:	CHF1.320

Financial Reports:

No articles found.

Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.